Evidence map›Paper›PMID 24056573›Full record

ArticleNanoscale2013

Modulation of hydrogel nanoparticle intracellular trafficking by multivalent surface engineering with tumor targeting peptide.

Leshern Karamchand, Gwangseong Kim, Shouyan Wang, Hoe Jin Hah, Aniruddha Ray, Ruba Jiddou, Yong-Eun Koo Lee, Martin A Philbert, Raoul Kopelman

Abstract read
In one paragraph

Article in Nanoscale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Homing Peptides for Cancer Therapy.Advances in experimental medicine and biology · 2021
    Review
  7. ACS nano · 2019
    Article
  8. Article
  9. Article
  10. Lifetime-resolved Photoacoustic (LPA) Spectroscopy for monitoring Oxygen change and Photodynamic Therapy (PDT).Proceedings of SPIE--the International Society for Optical Engineering · 2016
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leshern KaramchandDepartment of Chemistry, University of Michigan, 930 North University Ave, Ann Arbor, Michigan 48109, USA. kopelman@umich.edu.
Gwangseong Kim
Shouyan Wang
Hoe Jin Hah
Aniruddha Ray
Ruba Jiddou
Yong-Eun Koo Lee
Martin A Philbert
Raoul Kopelman

Funding

Nanoparticle Enabled Intraoperative Imaging and TherapyR01EB007977 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOPELMAN, RAOUL · 2007 to 2009
$2.8M
Nanobiophotonics Enabled Tumor Surgery and Intraoperative PDTR33CA125297 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOPELMAN, RAOUL · 2008 to 2010
$1.5M
NCI NIH HHS NIH/NCI R33CA125297NCI NIH HHS R33 CA125297NIBIB NIH HHS NIBIB R01 EB007977NIBIB NIH HHS R01 EB007977PHS HHS NIBIB R000262
6 · The paper itself

Abstract

Surface engineering of a hydrogel nanoparticle (NP) with the tumor-targeting ligand, F3 peptide, enhances both the NP's binding affinity for, and internalization by, nucleolin overexpressing tumor cells. Remarkably, the F3-functionalized NPs consistently exhibited significantly lower trafficking to the degradative lysosomes than the non-functionalized NPs, in the tumor cells, after internalization. This is attributed to the non-functionalized NPs, but not the F3-functionalized NPs, being co-internalized with Lysosome-associated Membrane Protein-1 (LAMP1) from the surface of the tumor cells. Furthermore, it is shown that the intracellular trafficking of the F3-functionalized NPs differs significantly from that of the molecular F3 peptides (untethered to NPs). This has important implications for designing effective, chemically-responsive, controlled-release and multifunctional nanodrugs for multi-drug-resistant cancers.

Indexed as

Acrylic ResinsAmino Acid SequenceAnimalsAnticarcinogenic AgentsCell Line, TumorChlorpromazineCytochalasin DEndocytosisGenisteinHumansHydrogel, Polyethylene Glycol DimethacrylateLysosomal-Associated Membrane Protein 1LysosomesMolecular Sequence DataNanoparticlesNucleolinAcrylic ResinsAnticarcinogenic AgentsChlorpromazineCytochalasin DGenisteinHydrogel, Polyethylene Glycol DimethacrylateLysosomal-Associated Membrane Protein 1NucleolinPeptidesPhosphoproteinsPolyacrylamidesRNA-Binding Proteins

Identifiers

PMID24056573
PMCPMC3823366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.